OCULOGENEX
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders. The company was founded in 2020 and is headquartered in La Habra, California.
OCULOGENEX
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
La Habra, California, United States
Country:
United States
Website Url:
http://www.oculogenex.com
Total Employee:
1+
Status:
Active
Contact:
562-726-4424
Email Addresses:
[email protected]
Total Funding:
281 K USD
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Valted Seq
Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.
Current Employees Featured
Founder
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - Oculogenex
MassChallenge
MassChallenge investment in Non Equity Assistance - Oculogenex
National Science Foundation
National Science Foundation investment in Grant - Oculogenex
Official Site Inspections
http://www.oculogenex.com
- Host name: box5877.bluehost.com
- IP address: 162.241.24.143
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
